Capricor Therapeutics
CAPR
$4.64
Share price
-3.13%
Change (1 day)
-5.69%
Change (1 year)
Categories
Number of shares outstanding for Capricor Therapeutics (CAPR)
Number of shares outstanding as of June 2024 : 31,354,629
According to Capricor Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 31,354,629. At the end of 2024 the company had 31,354,629 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Capricor Therapeutics from 2019 to 2024
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2024 | 31.35 M | 21.45% |
| 2023 | 25.81 M | 2.6% |
| 2022 | 25.16 M | 4.19% |
| 2021 | 24.15 M | 18.54% |
| 2020 | 20.37 M | 369.61% |
| 2019 | 4.33 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,430,100,000 | 7,650.37% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | 99,800,000 | 218.29% | 🇺🇸 USA |
 Cytokinetics
CYTK | 101,924,000 | 225.07% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 58,871,000 | 87.76% | 🇺🇸 USA |
 Palatin Technologies PTN | 15,792,421 | -49.63% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 5,410,000 | -82.75% | 🇺🇸 USA |